However, their combination in multimarker panels (including VEGF, MCP-1, and CA-125) achieves high diagnostic accuracy (sensitivity of 81-93%) in the non-invasive diagnosis of endometriosis, particularly when the phase of the menstrual cycle is taken into account (132, 133). This evidence concerns the gene CCL2 and endometriosis.